The BC Health Technology Assessment Committee (HTAC), comprised of representatives from each health authority, the Ministry of Health, and other professional members, is issuing its annual Call for Topics for 2022/23 as part of the BC Health Technology Assessment (BC HTA) process.
In 2011, the BC HTA process and HTAC were established to make evidence-informed recommendations about the public provision of health technologies based on their demonstrated clinical and cost-effectiveness. A health technology is defined as a procedure, device, and/or equipment involved in the maintenance, restoration, and/or promotion of health that is expected to have a significant patient and/or health system impact. It encompasses technologies used at any stage of care, including risk detection and disease prevention, early detection of disease, diagnosis, treatment, rehabilitation, and palliative care.
Examples of recently assessed technologies through the BC HTA process include glucose monitoring technologies for the management of insulin-dependent diabetes, a stepped model of care for major depressive disorder and generalized anxiety disorder, and MitraClip for percutaneous mitral valve repair.
Health technology assessments are produced by independent organizations and include a comprehensive review of the existing clinical evidence, input from both clinicians/health professionals and patients, and a BC-specific cost-effectiveness analysis and budget impact assessment. HTAC evaluates this evidence and makes recommendations to a committee made up of senior health authority and Ministry executives on whether or not to fund the health technology.
If you are aware of a) any health technologies that are not publicly funded (new assessment), or b) health technologies that are currently being used but whose benefits may no longer be clear (reassessment), please complete the attached BC HTA Nomination Form and forward it to HTA.Office@gov.bc.ca by November 30th.